Activation of immune blood biomarkers from interferon gamma pathway distinguished long-term survivors (>=2 years) ...
Specialization as a Strategic Advantage Leading suppliers are distinguishing themselves by developing deep expertise in ...
January 13, 2026 - PRESSADVANTAGE - In the highly regulated field of medical device labeling translation, ensuring that ...
Scancell Holdings plc (AIM: SCLP), the developer of ImmunoBody and Moditope active immunotherapies to treat cancer, today announces a business ...
Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide ...
Azafaros, a company building a portfolio to become a leader in lysosomal storage disorders with the goal of addressing neurological symptoms, today announced that it will present at J.P. Morgan’s 44th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results